Attached files
| file | filename |
|---|---|
| 10-K - BODISEN BIOTECH, INC | v178697_10k.htm |
| EX-31.1 - BODISEN BIOTECH, INC | v178697_ex31-1.htm |
| EX-31.2 - BODISEN BIOTECH, INC | v178697_ex31-2.htm |
| EX-21.1 - BODISEN BIOTECH, INC | v178697_ex21-1.htm |
CERTIFICATIONS
OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Bo
Chen, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report
on Form 10-K of Bodisen Biotech, Inc. for the fiscal year ended
December 31, 2009 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such report fairly presents, in all material respects,
the financial condition and results of operations of Bodisen Biotech,
Inc.
|
Dated:
March 30, 2010
|
By:
|
/s/
Bo Chen
|
|
Bo
Chen
|
||
|
Chief
Executive Officer
|
I, Junyan
Tong certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the annual report
on Form 10-K of Bodisen Biotech, Inc. for the fiscal year ended
December 31, 2009 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such report fairly presents, in all material respects,
the financial condition and results of operations of Bodisen Biotech,
Inc.
|
Dated:
March 30, 2010
|
By:
|
/s/
Junyan Tong
|
|
Junyan
Tong
|
||
|
Chief
Financial Officer
|